Acknowledgments
This book was triggered by the July 1990 symposium that was organized by the Institute of Medicine to initiate the Decade of the Brain. The speakers listed below participated in the meeting and graciously cooperated during the preparation of the book:
* Huda Akil, Mental Health Research Institute, University of Michigan, Ann Arbor
Duane Alexander, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
Floyd E. Bloom, Department of Neuropharmacology, Scripps Clinic and Research Foundation, La Jolla, California
D. Allan Bromley, Executive Office of the President, Washington, D.C.
Barbara Bush, Washington, D.C.
Silvio Conte (deceased), United States House of Representatives, Washington, D.C.
** W. Maxwell Cowan, Howard Hughes Medical Institute, Bethesda, Maryland
Pete V. Domenici, United States Senate, Washington, D.C.
* Patricia Goldman-Rakic, Department of Neuroscience, Yale University School of Medicine, New Haven, Connecticut
Murray Goldstein, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland
Frederick K. Goodwin, Alcohol, Drug Abuse, and Mental Health Administration, Rockville, Maryland
Enoch Gordis, National Institute on Alcohol Abuse and Alcoholism, Alcohol, Drug Abuse, and Mental Health Administration, Rockville, Maryland
Alberto Grignolo, FIDIA Pharmaceuticals, Washington, D.C.
Roger Guillemin, Whittier Institute, La Jolla, California
David H. Hubel, Department of Neurobiology, Harvard University Medical School, Boston, Massachusetts
Lily Yeh Jan, Department of Physiology, University of California, San Francisco
Richard T. Johnson, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Lewis L. Judd, National Institute of Mental Health, Alcohol, Drug Abuse, and Mental Health Administration, Rockville, Maryland
Eric R. Kandel, Center for Neurobiology and Behavior, Columbia University, New York, New York
Carl Kupfer, National Eye Institute, National Institutes of Health, Bethesda, Maryland
Thomas W. Langfitt, The Glenmede Trust Company and The Pew Charitable Trusts, Philadelphia, Pennsylvania
Robert Lefkowitz, Duke University Medical Center, Durham, North Carolina
Alan I. Leshner, National Institute of Mental Health, Alcohol, Drug Abuse, and Mental Health Administration, Rockville, Maryland
David T. Mahoney, David Mahoney Ventures, New York, New York
Joseph B. Martin, School of Medicine, University of California, San Francisco
James O. Mason, Department of Health and Human Services, Washington, D.C.
Guy M. McKhann, Zanvyl Krieger Mind/Brain Institute, Johns Hopkins University, Baltimore, Maryland
Vernon B. Mountcastle, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland
Michael I. Posner, Department of Psychology, University of Oregon, Eugene
* Dominick P. Purpura, Albert Einstein College of Medicine, Bronx, New York
* Marcus E. Raichle, Washington University School of Medicine, St. Louis, Missouri
Pasko Rakic, Section of Neuroanatomy, Yale University School of Medicine, New Haven, Connecticut
* Lewis P. Rowland, Department of Neurology, College of Physicians & Surgeons, Columbia University, New York, New York
Charles R. Schuster, National Institute on Drug Abuse, Alcohol, Drug Abuse, and Mental Health Administration, Rockville, Maryland
Terrence J. Sejnowski, Computational Neurobiology Laboratory, Salk Institute, San Diego, California
* Solomon H. Snyder, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland
Louis W. Sullivan, Department of Health and Human Services, Washington, D.C.
James D. Watson, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
T. Franklin Williams, National Institute on Aging, National Institutes of Health, Bethesda, Maryland
* Member, Steering Committee |
** Chair, Steering Committee |